AstraZeneca contributes to global rescue effort for Haiti

Wednesday, 13 January 2010

AstraZeneca is contributing to the global rescue effort in the wake of Haiti’s devastating earthquake. We have donated antibiotic and respiratory medicines (Meronem, Pulmicort and Rhinocort) through US charity AmeriCares and through Health Partners International in Canada, cardiovascular, gastrointestinal and respiratory (Tenormin, Losec, Nexium, Bricanyl, Pulmicort Turbuhaler) medicines.

In addition to our initial donation of $160,000, we have now donated a further $340,000 to the British Red Cross Emergency Appeal. We have also committed an additional $500,000 to support a longer-term disaster recovery programme that will give the people of Haiti the help they need to re-build their lives and their communities. We are currently working with AstraZeneca colleagues in the region to identify appropriate projects and partners.

LabTalk is AstraZeneca’s science-focused blog where you can hear from scientists, researchers and academics discussing novel ideas, research and innovation.

Biomedical_innovation_THM 19 September 2014

Biomedical innovation in emerging markets – understanding the strengths and weaknesses of individual markets

ctDNA_THM 10 September 2014

Smart testing in personalised healthcare – ctDNA is set to change the clinical diagnostic landscape

Collaborating_long_term_THM 4 September 2014

Collaborating for the long term: the meeting of industry and academia to improve drug research